SCHEMBL2907252

SCHEMBL2907252

CC(C)(C)OC[C@H](NC(=O)c1cn(CCCNc2ccc([N+](=O)[O-])c(N)n2)cc1-c1ccc(Cl)cc1Cl)C(=O)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 4/20 0.44
GSK3A P49840 3/20 0.44
CDK1 P06493 2/20 0.40
CCNB2 O95067 1/20 0.40
CCNB1 P14635 1/20 0.40
CCNB3 Q8WWL7 1/20 0.40
BACE1 P56817 2/20 0.39
GRN P28799 1/20 0.37
SORT1 Q99523 1/20 0.37
FOLH1 Q04609 1/20 0.35
ALDH1A1 P00352 2/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
PYGL P06737 1/20 0.32
CYP2C9 P11712 1/20 0.32
GART P22102 1/20 0.30
MAPT P10636 2/20 0.30
HTT P42858 2/20 0.30
MEN1 O00255 1/20 0.30
LMNA P02545 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2912945 0.94 GSK3B (0.43) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL1219461 0.85 GSK3B (0.49) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2910831 0.85 GSK3B (0.48) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL12892551 0.85 GSK3B (0.48) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2904789 0.85 GSK3B (0.48) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2907075 0.85 GSK3B (0.47) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2912808 0.84 GSK3B (0.46) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2905325 0.84 GSK3B (0.48) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2907714 0.84 GSK3B (0.42) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL1219415 0.84 GSK3B (0.51) GSK3BGSK3ACDK1CCNB2CCNB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1537099-B1 PYRROLE BASED INHIBITORS OF GLYCOGEN SYNTHASE KINASE 3 NOVARTIS VACCINES & DIAGNOSTIC (US) 2010-08-11 EP disclosed